Inventor · disambiguated record
Seble Lemma
Also filed as: LEMMA SEBLE
4 granted patents·1 pending application·21 citations·filing 2015–2018
72Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD5
Top patents by PatentIndex Score
5 records- 0191US10513517B2Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 24, 2019·11 cites·3 claims
- 0284US10144733B2Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Dec 4, 2018·5 cites·13 claims
- 0378US10487080B2Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Nov 26, 2019·3 cites·23 claims
- 0476US10004724B2Compounds alpha v beta 6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jun 26, 2018·2 cites·17 claims
- 0543US2021206758A1Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seble Lemma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →